DexCom, Inc. DXCM

Healthcare — Medical Devices

86.62 (0.85) (0.97%) as of 25 Sep

Market cap: $33.0B
P/E: 33.4×

Follow DXCM

S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years,

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
Net Income	836.30	576.20	541.50	341.20	216.90	549.70	101.10	(127.10)	(50.20)	(65.60)
Depreciation & Amortization	251.80	217.70	186.00	155.90	102.00	67.10	48.70	29.10	16.10	15.00
Non Cash Items (Other)	249.20	86.80	17.80	145.70	255.60	(120.40)	158.60	262.10	123.50	113.10
Accounts Receivable Change	(201.90)	(35.00)	(260.10)	(199.90)	(75.50)	(142.30)	(60.00)	(93.20)	(31.80)	(27.20)
Change in inventories	(63.70)	12.40	(252.60)	49.30	(112.20)	(114.50)	(49.10)	(25.50)	0.40	(9.80)
Change in payables and accrued liability	402.40	151.70	503.70	303.60	68.40	220.60	125.00	80.00	35.90	29.60
Change in other assets and liabilities	(33.40)	(20.30)	12.20	(126.30)	(12.70)	15.40	(9.80)	(2.20)	(1.90)	1.10
Operating Cash Flow	1,440.70	989.50	748.50	669.50	442.50	475.60	314.50	123.20	92.00	56.20
Capital expenditures	(363.50)	(358.80)	(236.60)	(364.80)	2,277.10	(199.00)	(180.00)	(67.10)	(66.00)	(55.70)
Net Aquisitions	—	—	—	(3.90)	(30.20)	—	—	(11.30)	—	0.30
Long-Term Investments Change (Net)	898.90	166.80	(272.50)	(153.00)	(2,473.10)	(807.70)	(834.00)	(60.40)	(78.40)	(0.50)
Other investing activities	0.60	(15.50)	1.90	0.20	10.10	(11.30)	(1.20)	(1.00)	—	—
Investing cash flow	536.00	(207.50)	(507.20)	(521.50)	(216.10)	(1,018.00)	(1,015.20)	(139.80)	(144.40)	(55.90)
Repayment/Issuance of Debt (Net)	(1,207.50)	—	443.30	—	—	906.20	—	617.70	389.00	(2.30)
Equity Repurchase (Common, Net)	(471.90)	(721.80)	(662.10)	(535.20)	20.30	15.30	11.90	94.60	10.10	10.40
Other financial activities	(7.00)	(13.00)	(99.80)	(17.30)	(9.90)	(9.40)	(1.20)	(1.90)	123.50	(2.30)
Financing cash flow	(1,686.40)	(734.80)	(318.60)	(552.50)	10.40	912.10	10.70	710.40	399.10	8.10
Exchange Rate Adjustment	21.50	(7.40)	1.50	(5.80)	(1.40)	2.10	(0.70)	1.80	0.30	0.00
Change in Cash	311.80	39.80	(75.80)	(410.30)	235.40	371.80	(690.70)	695.60	347.00	8.40
Beginning Cash	607.30	567.50	643.30	1,053.60	818.20	446.40	1,137.10	441.50	94.50	86.10
Ending Cash	919.10	607.30	567.50	643.30	1,053.60	818.20	446.40	1,137.10	441.50	94.50
Stock Based Compensation	159.60	170.40	150.80	126.50	113.40	119.40	102.70	101.90	106.20	110.80
Dividends Paid (Common)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash/Marketcap	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Assets Liabilities Change (Total)	103.40	108.80	3.20	26.70	(132.00)	(20.80)	6.10	(40.90)	2.60	(6.30)
Investments Change (Net)	898.90	166.80	(272.50)	(153.00)	(2,473.10)	(807.70)	(834.00)	(60.40)	(78.40)	(0.50)
Issuance/Purchase of Shares	(471.90)	(721.80)	(662.10)	(535.20)	20.30	15.30	11.90	94.60	10.10	10.40
Other line items
Revenue per Employee	0.42	0.39	0.38	0.38	0.35	0.30	0.38	0.37	0.24	0.25

Fold the line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

DexCom, Inc. DXCM